[1]
2025. Impact of Dupilumab on the Ability to Enjoy Life in Patients With Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s596. DOI:https://doi.org/10.25251/zsezf336.